Compare Stocks: HIMS, DLO, and TEM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DLO DLocal	$14.02 +0.2%	$14.42	$10.64 ▼ $16.15	$4.14B	0.95	2.05 million shs	949,733 shs
HIMS Hims & Hers Health	$20.64 +7.9%	$28.10	$13.74 ▼ $40.99	$4.81B	2.53	22.39 million shs	18.78 million shs
TEM Tempus AI	$79.81 -0.9%	$72.08	$40.77 ▼ $89.09	$14.54B	3.61	6.25 million shs	3.27 million shs

The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DLO DLocal	-2.78%	+6.15%	-8.14%	-2.03%	-1.20%
HIMS Hims & Hers Health	-16.89%	-25.98%	-38.35%	-36.21%	-53.72%
TEM Tempus AI	-4.62%	+3.52%	+13.55%	+47.48%	+12.20%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DLO DLocal	$14.02 +0.2%	$14.42	$10.64 ▼ $16.15	$4.14B	0.95	2.05 million shs	949,733 shs
HIMS Hims & Hers Health	$20.64 +7.9%	$28.10	$13.74 ▼ $40.99	$4.81B	2.53	22.39 million shs	18.78 million shs
TEM Tempus AI	$79.81 -0.9%	$72.08	$40.77 ▼ $89.09	$14.54B	3.61	6.25 million shs	3.27 million shs

The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DLO DLocal	-2.78%	+6.15%	-8.14%	-2.03%	-1.20%
HIMS Hims & Hers Health	-16.89%	-25.98%	-38.35%	-36.21%	-53.72%
TEM Tempus AI	-4.62%	+3.52%	+13.55%	+47.48%	+12.20%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DLO DLocal	2.83	Moderate Buy	$19.00	36.54% Upside
HIMS Hims & Hers Health	2.13	Hold	$31.53	55.60% Upside
TEM Tempus AI	2.45	Hold	$79.37	-1.75% Downside

Current Analyst Ratings Breakdown

Latest HIMS, DLO, and TEM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/10/2026	HIMS Hims & Hers Health	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Hold	$31.00 ➝ $24.00
11/10/2026	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Equal Weight	$28.00 ➝ $25.00
11/10/2026	HIMS Hims & Hers Health	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$42.00 ➝ $32.00
11/4/2026	HIMS Hims & Hers Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D)
11/3/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$80.00 ➝ $100.00
11/3/2026	TEM Tempus AI	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Underperform ➝ Hold	$35.00 ➝ $70.00
11/3/2026	TEM Tempus AI	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$80.00 ➝ $92.00
11/3/2026	TEM Tempus AI	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Outperform	$85.00 ➝ $92.00
11/3/2026	TEM Tempus AI	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$68.00 ➝ $85.00
11/2/2026	DLO DLocal	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (B-) ➝ Hold (C+)
11/2/2026	TEM Tempus AI	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$75.00 ➝ $89.00

(Data available from 11/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DLO DLocal	$1.09B	3.75	$0.88 per share	15.75	$1.93 per share	7.21
HIMS Hims & Hers Health	$2.35B	2.01	$0.74 per share	27.41	$2.38 per share	8.52
TEM Tempus AI	$1.27B	11.59	N/A	N/A	$2.74 per share	29.48

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DLO DLocal	$196.80M	$0.67	20.75	12.88	N/A	15.04%	41.64%	12.96%	11/12/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	46.06	N/A	-6.65%	-9.17%	-1.49%	N/A
TEM Tempus AI	-$245.03M	-$1.06	N/A	N/A	N/A	-12.54%	-47.00%	-9.44%	N/A

Latest HIMS, DLO, and TEM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	Q3 2026	DLO DLocal	$0.2091	N/A	N/A	N/A	$408.48 million	N/A
11/2/2026	Q3 2026	TEM Tempus AI	-$0.0937	$0.07	+$0.1637	-$0.08	$409.39 million	$411.54 million
8/14/2026	Q2 2026	DLO DLocal	$0.1841	$0.18	-$0.0041	$0.18	$366.77 million	$399.66 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DLO DLocal	$0.20	1.44%	N/A	29.85%	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DLO DLocal	N/A	1.25	1.25
HIMS Hims & Hers Health	4.21	0.93	0.87
TEM Tempus AI	2.70	2.61	2.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DLO DLocal	90.13%
HIMS Hims & Hers Health	63.52%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
DLO DLocal	45.44%
HIMS Hims & Hers Health	11.76%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DLO DLocal	1,274	294.93 million	160.92 million	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
TEM Tempus AI	3,800	182.40 million	138.15 million	Optionable

HIMS, DLO, and TEM Headlines

Recent News About These Companies

Tempus to Present Six Abstracts Accepted at the 2026 Connective Tissue Oncology Society Annual Meeting

4 hours ago | aol.comA

The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom

...

November 11 at 8:10 AM | marketbeat.com

Pictet Asset Management Holding SA Buys 486,493 Shares of Tempus AI, Inc. $TEM

November 11 at 5:31 AM | marketbeat.com

Top Artificial Intelligence Stocks To Follow Now - November 10th

November 10 at 12:14 PM | marketbeat.com

Blood Cancer United Launches REALworld: AML to Accelerate New Treatments for Children with Blood Cancer

November 10 at 9:00 AM | prnewswire.com

SOTERIA Precision Medicine Foundation Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer

November 10 at 3:49 AM | marketscreener.comM

Tempus AI (TEM) Stock Price Prediction: Bullish tape meets a near-term resistance test

November 9 at 5:48 PM | blockchain.newsB

SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer

November 9 at 4:39 PM | prnewswire.com

Large Language Model (LLM)-Powered Genomic Report Drafting Global Market Report 2026 | Capitalize on 23.6% CAGR Through 2030 with Illumina, QIAGEN, Tempus AI and SOPHiA GENETICS

November 9 at 12:37 PM | finance.yahoo.com

Genomic Variant Prioritization Artificial Intelligence (AI) Global Market Report 2026 | Capitalize on 26.5% CAGR with Illumina, QIAGEN, Thermo Fisher Scientific and Tempus AI

November 9 at 12:37 PM | finance.yahoo.com

Artificial Intelligence Stocks To Consider - November 9th

November 9 at 12:13 PM | marketbeat.com

Tempus AI: Q3 Strengthens The Platform Thesis, But Cash Returns Still Need To Catch Up

November 7, 2026 | seekingalpha.com

Tempus AI, Inc. Class A (TEM) Gets a Hold from J.P. Morgan

November 7, 2026 | theglobeandmail.com

MarketBeat Week in Review – 11/2 - 11/6 (TEM)

...

November 7, 2026 | marketbeat.com

Tempus AI (NASDAQ:TEM) Stock Breaks Above Fifty Day Moving Average - Time to Sell?

November 7, 2026 | marketbeat.com

Tempus AI, Inc. $TEM Shares Newly Purchased by Mirae Asset Global Investments Co. Ltd.

November 6, 2026 | marketbeat.com

Tempus AI, Inc. (NASDAQ:TEM) Stock Has Average Price Target of $79.37 According to Brokerages

November 6, 2026 | americanbankingnews.com

Tempus AI, Inc. (NASDAQ:TEM) Stock Has Average Target Price of $79.37

November 6, 2026 | marketbeat.com

Promising Artificial Intelligence Stocks To Follow Today - November 5th

November 5, 2026 | marketbeat.com

Tempus AI (NASDAQ:TEM) Director Sells $27,487.30 in Stock

November 5, 2026 | insidertrades.com

HC Wainwright Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock

November 5, 2026 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, DLO, and TEM Company Descriptions

DLocal NASDAQ:DLO

$14.02 +0.03 (+0.18%)

As of 03:38 PM Eastern

DLocal Limited operates a payment processing platform worldwide. The company offers pay-in solution which the business and get paid for their products and services through various payment methods, including international and local cards, online bank transfers and direct debit, cash, and alternative payment methods. It also provides pay-out solution used for merchants to scale pay-out operations. In addition, the company offers dLocal for Platforms, an end-to-end payment solution that offers a range of services to help platforms manage payments. It serves its products to commerce, streaming, ride-hailing, financial services, advertising, SaaS, travel, e-learning, on-demand delivery, and gaming and crypto industries. DLocal Limited was founded in 2016 and is headquartered in Montevideo, Uruguay.

Hims & Hers Health NYSE:HIMS

$20.64 +1.51 (+7.87%)

As of 03:38 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Tempus AI NASDAQ:TEM

$79.81 -0.73 (-0.90%)

As of 03:38 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, DLO, and TEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, DLO, and TEM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, DLO, and TEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, DLO, and TEM Company Descriptions

DLocal NASDAQ:DLO

Hims & Hers Health NYSE:HIMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, DLO, and TEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, DLO, and TEM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, DLO, and TEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, DLO, and TEM Company Descriptions

DLocal NASDAQ:DLO

Hims & Hers Health NYSE:HIMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools